Stock · NSE
GLENMARK 2,331.00 ▲ 0.00 (0.00%) Last 2 days · 15m candles 9/10/2026, 02:53:31
Open: 2,340.90 High: 2,351.80 Low: 2,285.50 Prev: 2,331.00
VERIFIED Mint Markets · 16d ★ ON YOUR LIST ☆
Top stocks to buy in F&O segment: Glenmark, Bharat Forge, Varun Beverages by Jay Thakkar - Check short-term targets AI summary · NEUTRAL
· Nifty 50 closed at 23,329, down 0.36%, and Sensex closed at 74,529, down 0.44% on September 22. · Domestic indices fell due to a decline in IT stocks, despite lower oil prices. · Technical analysis indicates a trading range for Nifty 50 between 23,000 and 24,000. Google News, NIFTY/SENSEX · 29d ★ ON YOUR LIST ☆
BEL to Glenmark - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment - TradingView Summarize with AI → VERIFIED Mint Markets · 29d ★ ON YOUR LIST ☆
BEL to Glenmark - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment AI summary · NEGATIVE
· Domestic benchmark indices opened lower on September 9. · Nifty 50 fell 0.56% to 23,511.40. · FII positions remained negative, contributing to broader market pressure. VERIFIED ET Markets · 32d ★ ON YOUR LIST ☆
10 midcap stocks with over 150% profit growth in Q1FY27 AI summary · POSITIVE
· Top 10 NSE midcap stocks reported over 150% YoY net profit growth in Q1FY27. · Glenmark Pharmaceuticals, Bharat Dynamics, and Poonawalla Fincorp showed strong financial performance. · The data was compiled from StockEdge for the June quarter. VERIFIED ET Stocks · 38d ★ ON YOUR LIST ☆
Is Nifty set for a breakout? Analysts see signs of a shift ahead AI summary · NEUTRAL
· Nifty is trading near 24,175 and needs to surpass 24,200 to strengthen. · Analysts are suggesting bullish option spreads for potential rebounds and advising caution if Nifty breaks below 23,900. · HEG, Laurus Labs, Glenmark Pharmaceuticals, Shipping Corporation of India, Newgen Software, and Elgi Equipments are highlighted as stocks with buying opportunities or positive chart setups. Google News, India stocks · 39d ★ ON YOUR LIST ☆
Stocks To Buy Today: Coforge, Timex To Glenmark Pharma — Five Stock Picks By Motilal Oswal's Chandan Taparia - NDTV Profit Summarize with AI → VERIFIED ET Stocks · 39d ★ ON YOUR LIST ☆
Corporate actions this week: NTPC, Coal India among nearly 90 stocks with record dates for bonus issues, stock splits and dividend payouts. Check full list AI summary · NEUTRAL
· Nearly 90 companies, including NTPC and Coal India, have record dates for corporate actions between August 31 and September 4. · These corporate actions include dividends, bonus issues, and stock splits. · Mastek, Glenmark Pharma, and Triveni Engineering are among the companies with record dates on Monday. VERIFIED Economic Times News · 39d ★ ON YOUR LIST ☆
Corporate actions this week: NTPC, Coal India among nearly 90 cos set to hit record dates for dividend payouts, bonus issues & stock splits AI summary · NEUTRAL
· Nearly 90 companies, including NTPC and Coal India, have record dates for corporate actions between August 31 and September 4. · These corporate actions include dividends, bonus issues, and stock splits. · Investors need to hold shares by the record date to be eligible for these actions. VERIFIED ET Markets · 39d ★ ON YOUR LIST ☆
Corporate actions this week: NTPC, Coal India among nearly 90 stocks with record dates for bonus issues, stock splits and dividend payouts. Check full list AI summary · NEUTRAL
· Nearly 90 companies, including NTPC and Coal India, have record dates for corporate actions between August 31 and September 4. · These corporate actions include dividends, bonus issues, and stock splits. · Investors need to hold shares by the record date to be eligible for these actions. VERIFIED ET Stocks · 41d ★ ON YOUR LIST ☆
Laurus Labs among 5 stocks hitting 52-week highs; surge up to 20% in a month AI summary · POSITIVE
· Six BSE 200 stocks reached new 52-week highs on Friday. · Coforge, GSK Pharma, Glenmark Pharma, Laurus Labs, Oracle Financial Services Software, and Piramal Finance demonstrated strong upward momentum. · Several of these stocks recorded double-digit percentage increases over the past month. VERIFIED Mint Markets · 48d ★ ON YOUR LIST ☆
Buy or sell: Gift Nifty signals gap-up start, Vaishali Parekh recommends three stocks to buy today — 21 August 2026 AI summary · NEUTRAL
· Gift Nifty signals a gap-up start for the Indian stock market. · Vaishali Parekh has recommended three stocks for trading today. · The recommended stocks are Hindustan Zinc, DCB Bank, and Glenmark Pharma. VERIFIED ET Stocks · 48d ★ ON YOUR LIST ☆
Glenmark Pharmaceuticals among 5 stocks showing bullish RSI upswing AI summary · POSITIVE
· Five Nifty500 stocks, including Glenmark Pharmaceuticals, showed a bullish RSI upswing on August 20. · These stocks gained over 4% on the identified date. · An uptrend signal is generated when the RSI value crosses above 50 from below. VERIFIED Mint Markets · 49d ★ ON YOUR LIST ☆
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 21 August 2026 AI summary · NEUTRAL
· Nifty 50 closed at 24,231.85 despite recent losses. · Analysts recommend buying Dixon Technologies. · Analysts recommend buying Glenmark Pharmaceuticals and Eternal shares. VERIFIED Mint Companies · 57d ★ ON YOUR LIST ☆
Glenmark Pharma US subsidiary agrees to $15.28 million settlement with Humana in generic drug antitrust case AI summary · NEUTRAL
· Glenmark Pharma's US subsidiary will pay $15.28 million to settle a lawsuit with Humana. · The lawsuit involved allegations of generic drug pricing. · Market allocation was also a point of contention in the litigation. VERIFIED ET Finance · 79d ★ ON YOUR LIST ☆
Glenmark sees innovative products driving 70% revenue in 5-6 years: CMD Glenn Saldanha AI summary · POSITIVE
· Glenmark expects innovative products to contribute 70% of its revenue in 5-6 years. · The company is developing next-generation products for oncology and complex diseases. · Glenmark aims to become a global oncology powerhouse within ten years, leveraging AI for drug discovery. VERIFIED ET Finance · 79d ★ ON YOUR LIST ☆
Glenmark gets USFDA nod for expanded use of RYALTRIS nasal spray AI summary · POSITIVE
· Glenmark Pharmaceuticals announced US FDA approval for RYALTRIS nasal spray. · The approval expands its use to children aged six to twelve years. · RYALTRIS treats symptoms of seasonal allergic rhinitis and combines antihistamine and corticosteroid. VERIFIED ET Stocks · 93d ★ ON YOUR LIST ☆
Stocks in news: Adani Enterprises, Cochin Shipyard, IDFC First Bank, Premier Energies, Glenmark Pharma AI summary · NEUTRAL
· Cochin Shipyard's offer for sale received strong investor demand on its first day. · Adani Enterprises' US legal case is likely to be dismissed by federal prosecutors. · IDFC First Bank has launched provident fund payment services through its EPFO integration. VERIFIED ET Markets · 93d ★ ON YOUR LIST ☆
Stocks in news: Adani Enterprises, Cochin Shipyard, IDFC First Bank, Premier Energies, Glenmark Pharma AI summary · NEUTRAL
· Cochin Shipyard's offer for sale received strong investor demand on its first day. · Adani Enterprises' US legal case is likely to be dismissed by federal prosecutors. · IDFC First Bank has launched provident fund payment services through its EPFO integration. VERIFIED Mint Companies · 93d ★ ON YOUR LIST ☆
Beyond generics: Glenmark resets agenda with a bold 10-year pivot to global drug innovation, says chairman Saldanha AI summary · NEUTRAL
· Glenmark is pivoting towards global drug innovation with a 10-year plan. · The strategy involves licensing deals, partnerships, and commercialization in emerging markets. · Chairman Glenn Saldanha outlined the company's future direction. VERIFIED ET Finance · 94d ★ ON YOUR LIST ☆
Glenmark launches generic Olanzapine injection in US AI summary · NEUTRAL
· Glenmark Pharmaceuticals has launched a generic version of Olanzapine injection in the United States. · The injection is a treatment for schizophrenia and bipolar disorder. · This launch aims to expand Glenmark's injectable offerings and institutional market presence. VERIFIED Mint Markets · 128d ★ ON YOUR LIST ☆
After a dull Q4, Glenmark Pharma needs a booster shot to grow AI summary · NEUTRAL
· Glenmark Pharma is focusing on core operational execution for FY27 growth. · The company is looking past one-off licensing gains. · Investors are shifting their focus to operational execution. VERIFIED Mint Markets · 132d ★ ON YOUR LIST ☆
Q4 results today: Asian Paints, IndiGo, IREDA, Glenmark Pharma - 131 companies to announce earnings on 29 May AI summary · NEUTRAL
· 131 companies, including Asian Paints and IndiGo, will announce their Q4 results on May 29. · Analysts anticipate a weak performance for Asian Paints due to urban demand challenges. · NMDC's results are expected to provide insights into iron ore prices and demand trends. VERIFIED Mint Markets · 134d ★ ON YOUR LIST ☆
Mphasis to Glenmark - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment AI summary · NEGATIVE
· Gift Nifty indicates a lower opening for the Indian market, down 97 points at 23,882. · Benchmark indices experienced a decline due to profit-taking and increasing crude oil prices. · Nifty 50 is encountering resistance at 24,100 and support at 23,800. Google News, India stocks · 137d ★ ON YOUR LIST ☆
Stocks to Watch Today: TVS Motor, Exide Industries, Meesho, Groww, Gujarat Themis, Glenmark Pharma,... - Moneycontrol.com Summarize with AI → VERIFIED Mint Markets · 139d ★ ON YOUR LIST ☆
Stocks to buy for short term: Glenmark Pharma, Manappuram Finance … Ajit Mishra of Religare Broking suggests 3 shares AI summary · NEUTRAL
· Ajit Mishra of Religare Broking has identified three stocks for short-term gains. · Glenmark Pharmaceuticals is among the stocks recommended. · Manappuram Finance is also highlighted as a potential short-term investment.